Vivotif
NDC 50632-016, Salmonella typhi Ty21a, capsule, coated, from Bavarian Nordic A/S.
- Product NDC
- 50632-016
- Status
- Listed
- Labeler
- Bavarian Nordic A/S
- Dosage form
- CAPSULE, COATED
- Route
- ORAL
- Product type
- VACCINE
- Marketing category
- BLA
- Application
- BLA103123
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/50632-016 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- SALMONELLA TYPHI TY21A LIVE ANTIGEN6000000000 [CFU]/1
Pharmacologic classes
Actively Acquired Immunity [PE]; Live Attenuated Salmonella Typhi Vaccine [EPC]; Vaccines, Attenuated [CS]; Vaccines, Typhoid [CS]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 50632-016-02 | 50632001602 | 1 BLISTER PACK in 1 CARTON (50632-016-02) / 4 CAPSULE, COATED in 1 BLISTER PACK (50632-016-04) |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
No FDA label, Medicare Part B payment limit or NADAC price is linked to this product.
Use it
Look up 50632-016 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/50632-016 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 50632-016. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.